Conclusions
This case shows the feasibility and safety of HCR in selected patients with multivessel CAD, highlighting how this hybrid technique combines the advantages of surgical and percutaneous revascularization, both guided by robotic techniques, eliminating at the same time some of the disadvantages of both procedures. Moreover, the use of RE-MIDCAB graft of the LIMA to the LAD and R-PCI to treat non LAD lesions could lead to additional benefits in optimizing patient outcomes.
This case report of robotically-enhanced hybrid revascularization is an example of a search towards a “value-based cardiovascular care” in which the enhanced outcome mattering to the patient together with the cost reduction through shortening of hospitalization and reduction of well-known complications are the capital elements of the equation.